Related Experiment Video
Updated: Dec 25, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Long non-coding (lnc)RNA PAPAS overexpression inhibits tumor growth in papillary thyroid carcinoma by downregulating
Juan Xiao1, Zhaowei Bing1, Ge Xiao2
1Department of Endocrinology, Qingdao Municipal Hospital, Qingdao, Shandong 266000, P.R. China.
Abstract:
The long non-coding (lnc)RNA pre-ribosomal RNA antisense transcripts (PAPAS) can repress ribosomal RNA synthesis, although its role in human disease is currently unknown. The present study aimed to investigate the function of PAPAS in papillary thyroid carcinoma (PTC). PAPAS was downregulated, while the lncRNA HOXA transcript at the distal tip (HOTTIP) was upregulated in patients with PTC. PAPAS and HOTTIP were inversely associated in PTC. PAPAS overexpression led to the downregulation of HOTTIP in PTC cells, while PAPAS expression was not significantly affected by HOTTIP overexpression, suggesting that PAPAS was upstream of HOTTIP. PAPAS expression level decreased, while HOTTIP expression level increased with the increase of clinical staging. PAPAS overexpression led to the inhibition of cell proliferation, while HOTTIP overexpression increased proliferation of PTC cells, and HOTTIP overexpression decreased the effects of PAPAS overexpression. lncRNA PAPAS overexpression may inhibit tumor growth in papillary thyroid carcinoma by downregulating lncRNA HOTTIP.
Insights
Long non-coding RNA PAPAS inhibits papillary thyroid carcinoma (PTC) growth by downregulating HOTTIP. PAPAS is downregulated, while HOTTIP is upregulated in PTC, suggesting PAPAS
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play crucial roles in cellular processes.
- The lncRNA pre-ribosomal RNA antisense transcripts (PAPAS) is known to repress ribosomal RNA synthesis.
- The specific role of PAPAS in human diseases, particularly cancer, remains largely unexplored.
Purpose of the Study:
- To investigate the functional role of PAPAS in the development and progression of papillary thyroid carcinoma (PTC).
- To elucidate the relationship between PAPAS and another lncRNA, HOTTIP, in the context of PTC.
Main Methods:
- Quantitative real-time PCR was used to assess PAPAS and HOTTIP expression levels in PTC tissues and cell lines.
- Functional assays, including cell proliferation and cell cycle analysis, were performed following PAPAS and HOTTIP overexpression or knockdown.
- Western blotting was employed to examine protein expression changes.
Main Results:
- PAPAS expression was significantly downregulated in PTC tissues compared to normal thyroid tissues.
- HOTTIP expression was inversely correlated with PAPAS expression in PTC patients.
- Overexpression of PAPAS inhibited PTC cell proliferation and downregulated HOTTIP expression, suggesting PAPAS acts upstream of HOTTIP.
- Conversely, HOTTIP overexpression promoted PTC cell proliferation and partially reversed the inhibitory effects of PAPAS overexpression.
Conclusions:
- lncRNA PAPAS functions as a tumor suppressor in papillary thyroid carcinoma.
- The tumor-suppressive role of PAPAS in PTC is mediated, at least in part, by the downregulation of lncRNA HOTTIP.
- PAPAS may serve as a potential therapeutic target for papillary thyroid carcinoma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Non-LTR Retrotransposons
The Nucleolus
Abnormal Proliferation